Huntington’s disease treated successfully for first time.

imhotep

Well-known member
  • Mar 29, 2017
    14,833
    8
    35,357
    113
    Surgical procedure to treat devastating illness slowed progress of disease by 75% in patients after three years.

    Huntington’s disease, a devastating degenerative illness that runs in families, has been treated successfully for the first time in a breakthrough gene therapy trial. It is one of the cruellest and most devastating diseases.

    The disease, caused by a single gene defect, steadily kills brain cells leading to dementia, paralysis and ultimately death. Those who have a parent with Huntington’s have a 50% chance of developing the disease, which until now has been incurable.

    Mutations in the HTT gene cause Huntington's disease. The HTT gene provides instructions for making a protein called huntingtin. Although the function of this protein is unclear, it appears to play an important role in nerve cells (neurons) in the brain.

    The gene therapy slowed the progress of the disease by 75% in patients after three years.

    Prof Sarah Tabrizi, the director of University College London’s Huntington’s disease centre, who led the trial, said: “We now have a treatment for one of the world’s more terrible diseases. This is absolutely huge. I’m really overjoyed.”

    The drug, which inactivates the mutant protein that causes Huntington’s, is delivered to the brain in a single shot during a 12- to 20-hour surgical procedure, meaning that it will be expensive. The breakthrough is sending ripples of hope through the Huntington’s community, many of whom have witnessed the brutal impact of the disease on family members.

    The first symptoms, which typically appear when the affected person is in their 30s or 40s, include mood swings, anger and depression. Later patients develop uncontrolled jerky movements, dementia and ultimately paralysis, with some people dying within a decade of diagnosis.

    With treatment, people would be able to work and live independently for significantly longer, Tabrizi said, and the dramatic impact of the therapy raises the possibility that it could prevent symptoms occurring if given at an earlier stage.

     
    Last edited:

    imhotep

    Well-known member
  • Mar 29, 2017
    14,833
    8
    35,357
    113
    HTT caused by a tri-nucleotide repeat that get accumilated in the neurons, What does the virus carry? RNA code for a inhibiting/ Binding protein??
    The virus (the usual adeno type) is only the vector that acts as a trojan. It contains the blueprints to make a special genetic molecule that sticks to the instructions cells normally use to make the huntingtin protein thus marking them for destruction.
    Check the uniQure site, they might have more details.
     

    imhotep

    Well-known member
  • Mar 29, 2017
    14,833
    8
    35,357
    113
    Sorry didn't notice your thread.... ☹️

    ඇහුවෙත් අදමයි බන් මේ ලෙඩ නම්. අපිටත් ටිනවද දන්නේ නැ මේ වගේ ලෙඩ.. දන්නෙම නැතුව හොදවෙලත් යනවා ඇති
    Mostly affects those with European descent. Significantly lower incidence with the Asians.
    ------ Post added on Sep 25, 2025 at 5:17 PM
     

    ex-muslim Ahmed

    Well-known member
  • Mar 7, 2009
    3,355
    767
    113
    HTT caused by a tri-nucleotide repeat that get accumilated in the neurons, What does the virus carry? RNA code for a inhibiting/ Binding protein??
    The virus (the usual adeno type) is only the vector that acts as a trojan. It contains the blueprints to make a special genetic molecule that sticks to the instructions cells normally use to make the huntingtin protein thus marking them for destruction.
    Check the uniQure site, they might have more details.
    මේක ජීන් තෙරපි මෙතඩ් එකක්. AAV5 වයිරස් එක ඩිලිවරි වෙක්ටර් එක, ඩිලිවර් කරන්නේ AMT-130 මයික්‍රෝ RNA . පහු ගිය අවුරුද්දේ නොබෙල් ප්‍රයිස් එක දුන්නේ මයික්‍රො RNA සොයාගැනීම වෙනුවෙන්. මේ ඒ ගැන විඩ්යෝ එක!

     

    imhotep

    Well-known member
  • Mar 29, 2017
    14,833
    8
    35,357
    113
    මේක ජීන් තෙරපි මෙතඩ් එකක්. AAV5 වයිරස් එක ඩිලිවරි වෙක්ටර් එක, ඩිලිවර් කරන්නේ AMT-130 මයික්‍රෝ RNA . පහු ගිය අවුරුද්දේ නොබෙල් ප්‍රයිස් එක දුන්නේ මයික්‍රො RNA සොයාගැනීම වෙනුවෙන්. මේ ඒ ගැන විඩ්යෝ එක!
    Correct...I didn't write too much details due to time constraints. AMT-130 was tested since 2019. Thus the short answer.
    Also then I need to write about microRNA and mRNA as well.
    Note that there are at least two other drugs in development and both are injections to the spine. One is by Roche and the other by Wave-Precision. The latter attempts to lower the mutant form selectively. The others including AMT-130 does reduce both the mutant and the innocent native (wild-type) huntintin protein.